COVID-19 Monoclonal Antibodies
Middletown Medical is proud to now offer monoclonal antibody treatments for COVID-19 patients. Early monoclonal antibody treatment has been proven to prevent hospitalization and reduce the risk of death. Recommended treatment is within 72-hours of COVID-19 diagnosis, and patients should inquire about treatment as soon as they receive a positive result. However, treatment can be given up to 10 days post-diagnosis.
Monoclonal antibodies are currently the only recognized treatment for COVID-19 to prevent hospitalization.
Middletown Medical’s standard charge for this cutting-edge therapy is $2,250.
CLICK HERE TO REQUEST A TELEMEDICINE APPOINTMENT
TO VERIFY YOUR ELIGIBILITY.
Or, contact us to learn more: 845.342.4774
What are monoclonal antibodies?
Monoclonal antibodies are laboratory-produced molecules that act as substitute antibodies that can restore, enhance or mimic the immune system’s attack on cells.
How do monoclonal antibodies treat COVID-19?
How do I receive the treatment?
Middletown Medical’s Infusion Center features the latest in infusion treatment technology and has a specialized team to monitor your care during the antibody treatment.